Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response

Journal of Immunology

Volumn 165, Issue 8, 2000, Pages 4537-4543

  Weighardt, H ^a   Feterowski, C ^a   Veit, M ^a   Rump, M ^a   Wagner, H ^a   Holzmann, B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; OLIGODEOXYNUCLEOTIDE;

ARTICLE; BACTERIAL INFECTION; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; PRIORITY JOURNAL; SEPSIS; VIRUS INFECTION;

EID: 0034668119     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.8.4537     Document Type: Article

References (56)

1. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
2. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial
3. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein
4. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of Gram-negative sepsis
5. Treatmem of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin
6. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection
7. Sepsis after major visceral surgery is associated with sustained and interferon-γ-resistant defects of monocyte cytokine production
8. Dysregulation of in vitro cytokine production by monocytes during sepsis
9. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production
10. Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection
11. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
12. Mechanisms and therapeutic applications of immune stimulatory CpG DNA
13. Bacterial DNA as immune cell activator
14. Bacterial CpG DNA activates immune cells to signal infectious danger
15. Bacterial DNA causes septic shock
16. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
17. Macrophages ingest and are activated by bacterial DNA
18. Bacterial DNA and immunostimulatory CpG oligodeoxynucleotides trigger maturation and activation of murine dendritic cells
19. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
20. DNA activates human immune cells through a CpG sequence-dependent manner
21. CpG motifs in bacterial DNA trigger direct B-cell activation
22. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12, and interferon-γ
23. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by nonspecific endocytosis and endosomal maturation
24. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12
25. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines
26. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
27. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge
28. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection
29. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis
30. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses
31. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract
32. Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines
33. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hematopoiesis
34. Essential role of γ interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis
35. Mechanisms of acute inflammatory lung injury induced by abdominal sepsis
36. Flow cytometric identification of murine neutrophils and monocytes
37. Inverse relationship between the susceptibility of lipopolysaccharide (lipid A)-pretreated mice to the hypothermic and lethal effect of lipopolysaccharide
38. Protective effects and role of endotoxin in experimental septicemia
39. Monophosphoryl lipid a protects against gram-positive sepsis and tumor necrosis factor
40. Function and regulation of the neutrophil MEL-14 antigen in vivo: Comparison with LFA-1 and MAC-1
41. Leukocyte adhesion-deficient neutrophils fail to amplify phagocytic function in response to stimulation
42. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing
43. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease
44. The NADPH oxidase and chronic granulomatous disease
45. The genetic basis of chronic granulomatous disease
46. The p47(phox) mouse knockout model of chronic granulomatous disease
47. Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells
48. Endotoxin opens the Tollgates to innate immunity
49. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor
50. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
51. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor β
52. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
53. Critical protective role of mast cells in a model of acute septic peritonitis
54. Interleukin 1β improves survival following cecal ligation and puncture
55. Multiple roles for IL-12 in a model of acute septic peritonitis
56. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs clearance in murine Escherichia coli peritoneal sepsis